This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Crispr Therapeutics Ag. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Zinkal Samir Padalia: Innovator in Cancer Treatment
Introduction
Zinkal Samir Padalia is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative methods and compositions. With a total of 3 patents, Padalia is recognized for his dedication to advancing medical science.
Latest Patents
His latest patents focus on methods and compositions for treating cancer. These patents provide innovative approaches, including cell compositions, aimed at improving cancer treatment outcomes. The emphasis on developing effective methods showcases his commitment to addressing critical health challenges.
Career Highlights
Zinkal Padalia is currently associated with Crispr Therapeutics AG, a company known for its groundbreaking work in gene editing and therapeutic solutions. His role at the company allows him to collaborate with leading experts in the field, further enhancing his contributions to cancer research.
Collaborations
Padalia has worked alongside notable colleagues, including Jonathan Alexander Terrett and Demetrios Kalaitzidis. These collaborations have fostered a dynamic environment for innovation and research, leading to advancements in cancer treatment methodologies.
Conclusion
Zinkal Samir Padalia stands out as a dedicated inventor in the realm of cancer treatment. His innovative patents and collaborations reflect his commitment to improving healthcare solutions. Through his work, he continues to make a significant impact in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile